Disrupting the gut microbiome may affect some immune responses to flu vaccination

Researchers from Stanford University found that oral antibiotics, which can kill gut microorganisms, can alter the human immune response to seasonal influenza vaccination.

This colorized transmission electron micrograph depicts H1N1 influenza virus particles. Photo: National Institute of Allergy and Infectious Diseases

The normal human gut microbiome is a flourishing community of microorganisms, some of which can affect the human immune system.

The research team examined 33 healthy adult participants in their study. One group of 22 volunteers was studied during the 2014-2015 flu season, and the second group with 11 volunteers was studied during the 2015-2016 flu season.

The group of 22 volunteers had high pre-existing immunity to the influenza virus strains contained in the 2014-2015 seasonal influenza vaccine. The group of 11 volunteers had low immunity to the 2015-2016 seasonal influenza vaccine’s virus strains.

All study participants received a seasonal influenza vaccine. Half the participants in each group also received a five-day course of a broad-spectrum antibiotic regimen (consisting of neomycin, vancomycin, and metronidazole) by mouth before receiving the vaccine.

By analyzing stool and blood serum samples taken at various times up to one year after vaccination, the researchers tracked the participants’ immune response to the influenza vaccines, as well as the diversity and abundance of the organisms in their gut microbiomes.

As expected, most participants who received antibiotics experienced reduced levels of gut bacteria. In addition, among the 2015-2016 participants who had little prior immunity to the seasonal influenza virus vaccine strains, a course of antibiotics hindered their immune responses to one of the three influenza virus strains in the vaccine, an H1N1 A/California-specific virus.

This likely indicates that should they be exposed to this H1N1 virus after vaccination, these participants would be less protected against infection with that strain than people who had not received antibiotics, according to the authors. This finding supports earlier research results in mice.

The researchers also found that people who took antibiotics experienced changes to their immune systems that promoted a pro-inflammatory state, similar to a condition seen in older adults who have received influenza vaccines.

The investigators believe this pro-inflammatory state is related to the process by which the microbiome regulates the metabolism of bile acid—with fewer microorganisms, this process is disrupted. Humans’ microbiomes change naturally as they age, and the researchers suggest that further research on these pathways could provide insights into why older adults respond differently to influenza vaccination and why they have weaker immune systems overall. (National Institutes of Health)

YOU MAY ALSO LIKE

Nanoparticles used to transport anti-cancer agent to cells

Scientists from the University of Cambridge have developed a platform that uses nanoparticles known as metal-organic frameworks to deliver a promising anti-cancer agent to cells.

The brain may actively forget during dream sleep

Rapid eye movement, or REM, sleep is a fascinating period when most of our dreams are made. Now, in a study of mice, a team of Japanese and U.S. researchers show that it may also be a time when the brain actively forgets.

Zika virus found to harm adults’ memory and motor system

A study by scientists at the Federal University of Rio de Janeiro (UFRJ) found that the Zika virus, in addition to replicating in the brain of adults, also damages the memory and the motor system.

Molecule in Immune System Able to Trigger 'Suicide' of Cancerous Tumors

Researchers discovered a molecule in the immune system that could naturally kill cancer cells.

First-time pregnancy complications linked to increased risk of hypertension later in life

Women who experience complications such as preterm births and preeclampsia during their first pregnancy are nearly twice more likely than women without complications to develop high blood pressure later in life — some as quickly as three years later.

Novel nanogels hold promise for improved drug delivery to cancer patients

Researchers at The University of Texas at Austin have developed new guidelines for fabricating nanoscale gel materials, or nanogels, that can deliver therapeutic remedies to treat cancer in a precise manner.